Funder
Australian Research Council
Publisher
Springer Science and Business Media LLC
Reference144 articles.
1. Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019;20:490–507. https://doi.org/10.1038/s41580-019-0131-5.
2. Genetic Alliance. District of Columbia Department of Health Understanding genetics: a district of Columbia guide for patients and health professionals, in: Genetic Alliance Monographs and Guides. Washington (DC): Genetic Alliance; 2010.
3. Kotagama OW, Jayasinghe CD, Abeysinghe T. Era of genomic medicine: a narrative review on CRISPR technology as a potential therapeutic tool for human diseases. Biomed Res Int. 2019;2019:1369682. https://doi.org/10.1155/2019/1369682.
4. Gillet J-P, Macadangdang B, Fathke RL, Gottesman MM, Kimchi-Sarfaty C. The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer. In: Gene Therapy of Cancer. 2009.
5. Gupta RM, Musunuru K. Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J Clin Invest. 2014;124:4154–61. https://doi.org/10.1172/JCI72992.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献